Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.

The mutation status of genes encoding the variable region of immunoglobulin heavy chains (IgV(H)) is a strong predictor of disease progression and survival in B-cell chronic lymphocytic leukemia (B-CLL). We investigated whether there is an association between the concentration of both vascular endothelial growth factor and basic fibroblast growth factor and IgV(H) mutation status in 49 untreated B-CLL patients.

[1]  K. Kuliczkowski,et al.  Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia. , 2004, Analytical and quantitative cytology and histology.

[2]  D. Ribatti,et al.  Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. , 2002, Blood.

[3]  N. Kay,et al.  B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules , 2002, Leukemia.

[4]  O. Bairey,et al.  Bcl‐2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia , 2001, British journal of haematology.

[5]  E. Estey,et al.  Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. , 2000, Blood.

[6]  S. Molica,et al.  Increased serum levels of vascular endothelial growth factor predict risk of progression in early B‐cell chronic lymphocytic leukaemia , 1999, British journal of haematology.

[7]  A. König,et al.  Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis , 1997, Leukemia.

[8]  E. Calleja,et al.  Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. , 1996, Blood.

[9]  E. Montserrat,et al.  Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. , 2005, Haematologica.